טוען...
EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality
The clinical experience recently reported with epidermal growth factor receptor (EGFR)-targeting drugs confirms the synergistic interactions observed between these compounds and conventional cytotoxic agents, which were previously established at the preclinical stage. There are, however, examples of...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2453033/ https://ncbi.nlm.nih.gov/pubmed/18506149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604373 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|